Manuka Honey
PreclinicalBiologic
Manuka Honey is one of 4 biologic programs targeting Third Molar. It is currently in Preclinical.
1
Indications
3
Total Trials
0
Active Trials
3
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
4 competitors in Third Molar
#DrugCompanyPhaseTrials
1Xylocaine
MMEDRx USA, Inc.
Phase 3
Glucophage
EMD SeronoPhase 2
Arnica Montana
TThe University of Texas Health Science Center, Houston
Preclinical
Manuka Honey
TToyos Clinic
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Third Molar1 trial
The Use of Manuka Honey to Improve Healing After Third Molars Surgery
Completed·—·N/A·NCT02483741·50 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Manuka Honey. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Biologic[2]
- Highest Phase
- Preclinical[1]
- Company
- TToyos Clinic